Status:
COMPLETED
Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort
Lead Sponsor:
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Collaborating Sponsors:
Esteve
Conditions:
Contact Lens Complication
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
There are more than 140 million contact lens wearers in the world. However, contact lens use can cause discomfort symptoms in up to 50% of wearers. And these symptoms can lead to contact lens abandonm...
Detailed Description
Justification: The number of contact lens wearers is increasing every year. It is estimated that there are approximately more than 140 million wearers worldwide. However, around 50% of them suffer fr...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Signature of informed consent form
- Regular hydrophilic contact lens wearers: at least 4 times a week and at least 4 hours a day
- Contact lens discomfort measured as a Contact Lens Dry Eye Questionnaire-8 score higher than 11 points
Exclusion
- Known sensitivity or intolerance to some of the products used in the study
- Habitual non-compliance of the contact lens replacement frequency
- Any systemic disease or treatment that alters the eye
- Any ocular surgery, infection, inflammation, or active eye disease, in the last year
- Autoimmune dry eye
- Participation in a clinical trial within 30 days prior to entry into this study
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2024
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05290727
Start Date
March 1 2022
End Date
July 12 2024
Last Update
October 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IOBA - University of Valladolid
Valladolid, Spain, 47011